Pfizer cuts five cancer programs; George Church engages Cellectis' TALEN tech to create virus-resistant human cells
→ Pfizer $PFE has cut five of its oncology programs, according to the pharma giant’s pipeline update. The axed programs include a handful of preclinical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
